Field Applications Specialist II - Immunohistochemistry, Leica Biosystems
BIOGRAPHY
NOV 17, 2022 8:00 AM PST
Tips, Tricks, and Optimization: A User's Guide to BOND RX and Chromogenic Multiplexing in Research Applications
Speaker
Event Date & Time
Date: November 17, 2022
Time: 8:00 AM (PST), 11:00 AM (EST), 5:00 PM (CET)
Abstract
Have you ever wished you had access to the technical specialist who wrote the book on multiplexing applications?
Please join Leica Biosystems Life Science Field Applications Specialist Mark Lawson for this special event, where Mark shares the development timeline of IHC and multiplex staining on the BOND RX staining instrument and its role in driving cutting-edge technologies.
Mark will help identify common problems researchers face when developing protocols in IHC and multiplex staining and share some helpful guidance, tips, and tricks for BOND RX users in solving these dilemmas. Topics will include developing best practices for setting up and running chromogenic multiplex slides, providing participants with step-by-step guides on configuring the BOND RX v7.0 software, and sharing insights on optimizing IHC and multiplex staining.
Learning Objectives
- Recall two types of assays that can be run on the BOND RX
- Describe two ways researchers can optimize IHC and multiplex staining
- Identify one best practice solution for running chromogenic multiplexing
*For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after the live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...